Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 2.77MWorking Capital
VS
Market
Sector
Industry
History
$ 1.83Close
$ 1.7 - $ 5.85 52-Week Range
Ticker Information
Ticker
PPCBCompany Name
PROPANC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPROPANC BIOPHARMA INC - Working Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PPCB - Working Capital Historical data
| Date | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| 6/30/2025 | $ 8.35M | $ 5.58M | $ 2.77M |
| 3/31/2025 | $ 9.74M | $ 4.34M | $ 5.39M |
| 12/31/2024 | $ 17.98K | $ 4.15M | $ -4.14M |
| 9/30/2024 | $ 21.53K | $ 4.1M | $ -4.08M |
| 6/30/2024 | $ 25.44K | $ 3.79M | $ -3.77M |
| 3/31/2024 | $ 12.86K | $ 3.69M | $ -3.68M |
| 12/31/2023 | $ 210.82K | $ 3.76M | $ -3.55M |
| 9/30/2023 | $ 145.8K | $ 3.13M | $ -2.99M |
| 6/30/2023 | $ 19.04K | $ 3.16M | $ -3.14M |
| 3/31/2023 | $ 96.58K | $ 3.06M | $ -2.96M |
Key Performance Insights, Last 5 Years
- PROPANC BIOPHARMA INC's latest trailing twelve months (TTM) Working Capital stands at $ -3.05M.
- Over the past 5 years, PROPANC BIOPHARMA INC's average Working Capital has been $ -2.22M.
- The median Working Capital for PROPANC BIOPHARMA INC during this period was $ -3.05M
- PROPANC BIOPHARMA INC reached its highest Working Capital over the past 5 years at $ 5.39M.
- The lowest Working Capital recorded by PROPANC BIOPHARMA INC in the same timeframe $ -4.14M
Similar metrics to Working Capital:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Working Capital
[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].AssetsC - LiabilitesC
(=) Working Capital Working Capital for PROPANC BIOPHARMA INC is calculated as follows: AssetsC [ $ 15.03K ] - LiabilitesC [ $ 3.06M ]
(=) Working Capital [ $ -3.05M ] PPCB - Working Capital, Last 5 years
$ -4.14M
Minimum
Dec 31, 2024
$ 5.39M
Maximum
Mar 31, 2025
$ -2.22M
Average
$ -3.05M
Median
Working Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.1M with a standard deviation of $ 174.5M.
The following table provides additional summary stats:
Working Capital in the Market:
| filtered constituents | 2.78K |
|---|---|
| min | $ -468.61M |
| max | $ 607.04M |
| average | $ 96.1M |
| median | $ 32.21M |
| std | $ 174.5M |